SpeechPathology.com Phone: 800-242-5183


EDU Healthcare Opportunities

LSVT® Loud: Beyond Parkinson’s Disease

LSVT® Loud: Beyond Parkinson’s Disease
Nancye C. Roussel, Ph.D., CCC-SLP
April 1, 2014
Share:

>> Nancye Roussel:  Today we will be discussing LVST® Loud and its application to other disorders outside the realm of Parkinson's disease.  Looking at the learner objectives, what I hope to cover includes explaining the mechanism for improvement in subsystems outside phonation and voice with LSVT Loud, discussing the current levels of evidence for using LSVT Loud with other neurological populations, and then describing a couple of variations in service delivery that have some research support for use with other populations. 

LSVT®LOUD – The Program

How many of you have been through the LSVT Loud training?  It seems the majority of you have had the LSVT Loud training.  That is not the purpose of this course, but I did include some information about the program for those of you who have not had the training.  A small disclaimer - I am not associated with the LSVT Loud research.  As Amy said, I am an educator and I have been following the program since they first introduced it back in the early 90s.  I was at the Acoustical Society of America and they had a poster session there.  I was intrigued by the level of research that they had supporting this clinical program.  That is where my focus comes from - looking at the evidence behind the program so that I can recommend it to the students that I train and encourage them to go out and get the training. 

This is the basic program.  It is an intensive voice training program; one hour, four days a week for 14 weeks, with 16 total sessions.  The advantage of LSVT Loud for the patients with Parkinson's is that there is a continuous focus on just one goal: getting them to be louder.  It is shown that loudness training, the focus on sensory awareness, and the home practice that is incorporated from the beginning can have of very good effects on their overall intelligibility, articulation, and voice quality which are directly targeted. 

There have also been changes in the Parkinson's population in facial expression and in swallowing.  This program has over 20 years of research including some controlled trial efficacy data.  They have documented very well both short and long-term changes in vocal intensity, which is directly trained.  The vocal intensity they have tracked for up to two years in follow-up studies remains improved. 

Why Does It Work? Early Perspectives

Why does it work?  I looked back at some of the early perspectives and ideas from the group that has studied this extensively in Boulder, Colorado, extending down into research facilities in Arizona.  Early on, the researchers felt that the following three factors drove the improvement that we saw in the Parkinson's patients: 

  1. The improved vocal fold closure enhanced the carrier signal for the articulatory information.  Basically because the voice was improved, the modulation of the laryngeal signal produced clearer articulatory information and perception of speech was improved. 
  2. They also felt that perhaps increasing loudness stimulates an overall increased effort and coordination across the respiratory and articulatory system since these are certainly interconnected to one another.  By stimulating the patient to increase their effort to get louder, they were also increasing the precision of the articulatory system because they were using more effort and increasing the respiratory effort. 
  3. This very intensive treatment and the focus on sensory feedback helped to recalibrate the Parkinson's patient’s self-perception of how loudly they were speaking.  It improved their proprioceptive feedback and their internal auditory feedback.  One of the common things in the Parkinson's patients was that even though they could get louder, they felt like they were not talking loud enough.  These are early perspectives Fox, et al, 2002.

nancye c roussel

Nancye C. Roussel, Ph.D., CCC-SLP

Dr. Nancye Roussel is an associate professor and head of the Department of Communicative Disorders at the University of Louisiana at Lafayette.  She has 20+ years of experience in higher-education and is a practiced lecturer at workshops on voice, dysarthria and swallowing.  She is strong advocate of evidence-based practice and conducts a popular seminar each fall investigating the evidence for current treatments in voice and swallowing.



Related Courses

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video
Course: #9473Level: Intermediate1 Hour
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video
Course: #9732Level: Intermediate1 Hour
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

Best Practice for Assessment and Treatment of Bilingual Aphasia
Presented by Maria Muñoz, PhD, CCC-SLP
Video
Course: #9759Level: Intermediate1.5 Hours
This course focuses on best practice in the assessment and treatment of bilingual aphasia by speech-language pathologists. Recommended practices are contrasted against common mistakes made by clinicians working with bilingual patients with aphasia. Implementation of best practices are modeled through case studies.

Social Isolation and COVID-19 Cognitive Decline: From Zero to Hero!
Presented by Amber B. Heape, ClinScD, CCC-SLP, FNAP, CMD, CMDCP
Video
Course: #9514Level: Intermediate1 Hour
Social distancing and isolation associated with the COVID-10 pandemic have begun to take a toll on patients in residential settings, but SLPs can help mitigate the long-term consequences. This course will discuss the risk factors for and effects of isolation, as well as potential strategies to prevent or reverse pandemic-related cognitive decline.

Differential Diagnosis of the Dysarthrias: An innovative case analysis approach
Presented by Paul Blanchet, PhD, CCC-SLP
Text
Course: #8759Level: Intermediate1 Hour
This course demonstrates differential diagnosis of the dysarthrias using an "ELMS" analysis. Using a simple acronym, a clinician will be able to integrate available information pertaining to the Etiology, Lesion site, Motor signs, and Speech deficits to aid in an accurate diagnosis of the sub-type(s) of dysarthria.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.